"
Safety, Tolerability, and Pharmacokinetics of E3030, a Novel Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist, in Healthy Japanese Male Subjects"
written by Yutaka Takeuchi, Yuki Nishioka, Yasumi Kitahara, Setsuo Hasegawa, Akihiro Ohnishi,
published by
Pharmacology & Pharmacy,
Vol.5 No.2, 2014
has been cited by the following article(s):